ArticleTrials2023

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.

P Krausewitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.